Dhanuka Agritech has appointed Shalinder Singh as General Manager-Sales, effective August 3, 2026. The company made the disclosure to the National Stock Exchange of India Limited and BSE Limited on August 3, 2026, pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This leadership addition aims to strengthen the firm’s sales execution capabilities across key agricultural geographies.

The appointment was formalized through a full-time employment contract. Dhanuka Agritech’s Company Secretary & Compliance Officer, Jitin Sadana, signed the intimation letter submitted to the exchanges. The disclosure also referenced SEBI Master Circular No. HO/49/14/14(7)2025-CE D-POD/2/1/3762/2026 dated January 30, 2026, regarding the details required for senior management appointments.

New Leadership Profile

Shalinder Singh brings over 20 years of experience in sales and marketing within the agri-inputs sector. His professional background includes strong exposure to diverse agricultural geographies, specifically the cotton and paddy regions of Punjab. Singh possesses business acumen focused on executing sales and marketing strategies to establish market presence and drive revenue and profitability.

Previously, Singh held leadership positions at reputed organizations including Syngenta and Nagarjuna. He holds a Master of Science in Horticulture from Punjab Agriculture University, Ludhiana.

Appointment Details

The filing confirmed that there is no relationship between the appointee and the directors of the company that requires disclosure under the relevant regulations.

Dhanuka Agritech Limited reported a net profit of ₹363.04 crore for the quarter ended June 30, 2026 (Q1FY27), marking a 34.6% year-on-year decline from ₹555.03 crore in Q1FY26. Revenue from operations fell 12.6% to ₹4,619.28 million, primarily due to delayed monsoon onset in key agricultural regions which postponed sowing activities and reduced product demand. Despite the revenue contraction, the company maintained profitability with earnings per share (EPS) settling at ₹8.06, compared to ₹12.31 in the corresponding prior period.

The Board of Directors approved the unaudited financial results on August 03, 2026, reviewed by statutory auditors S S Kothari Mehta & Co. LLP. Alongside the results, shareholders approved a final dividend of 100%, amounting to ₹2 per equity share, during the 41st Annual General Meeting held on the same day. The company also confirmed its commitment to a ₹200 crore capital expenditure for a new pesticide manufacturing unit in Nagpur, Maharashtra, expected to be operational by April 2028.

Financial Performance Overview

Total income decreased to ₹4,707.91 million from ₹5,363.32 million in Q1FY26. EBITDA stood at ₹550.10 million, down 33.9% from ₹831.90 million in the previous year, with EBITDA margins contracting to 11.91% from 15.75%. Gross margins also slipped to 35.16% from 36.03%, reflecting price competition and weaker domestic demand. Other income remained relatively stable at ₹88.63 million, slightly up from ₹80.44 million.

Expenses totaled ₹4,222.17 million, down 8.6% year-on-year. Cost of materials consumed decreased to ₹2,871.33 million from ₹3,614.59 million. However, other expenses rose slightly to ₹609.41 million from ₹604.62 million. Tax expenses were recorded at ₹1,221.92 million, compared to ₹1,904.22 million in Q1FY26.

Strategic Initiatives and Shareholder Returns

The company is proceeding with the establishment of a new pesticide manufacturing facility in Nagpur, Maharashtra, with an estimated outlay of up to ₹200 crore. The plant will have an annual capacity of 23,000 MT and aims to leverage Maharashtra’s industrial incentives and Nagpur’s logistics hub status under the Viksit Nagpur plan. Financing will be sourced through internal accruals and/or debt.

Additionally, the Board approved an Employee Stock Option Plan (ESOP) to strengthen entrepreneurial mindset and align long-term interests. The company also granted approval for a loan of up to ₹15 crore to the Dhanuka Employee Stock Benefits Trust for implementing the "Dhanuka Stock Appreciation Rights Plan, 2026" under SEBI regulations. In terms of shareholder returns, the company recently completed a buyback of 5 lakh equity shares at ₹1,400 per share, absorbing ₹70 crore.

What the Numbers Show

A notable divergence exists between revenue growth and expense management. While revenue contracted by 12.6%, total expenses fell by only 8.6%, leading to a sharper decline in profit before tax (34.8%). This suggests that fixed costs or certain operational expenses did not scale down proportionally with the drop in sales volume. Furthermore, the decline in gross margin to 35.16% indicates pressure on pricing power amidst competitive dynamics. The company’s guidance for FY27 suggests lower single-digit revenue growth and an approximate 200 basis point decline in EBITDA, signaling continued headwinds in the near term.